Pharmacological basis and new insights of resveratrol action in the cardiovascular system

• Published in: British journal of pharmacology Vol. 177; no. 6; pp. 1258 - 1277
• Main Authors: Cheng, Chak Kwong, Luo, Jiang‐Yun, Lau, Chi Wai, Chen, Zhen‐Yu, Tian, Xiao Yu, Huang, Yu
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.03.2020; John Wiley and Sons Inc
• Subjects: Aging; Anti-Inflammatory Agents; Antioxidants; Arteriosclerosis; Cardiomyopathy; Cardiovascular diseases; Cardiovascular System; Circadian rhythms; Developmental stages; Dietary Supplements; Energy metabolism; Functional foods & nutraceuticals; Inflammation; Ischemia; Microbiota; Phytoalexins; Resveratrol; Resveratrol - pharmacology; Review; Themed Section: Review; Wine

Resveratrol (trans‐3,4′,5‐trihydroxystilbene) belongs to the family of natural phytoalexins. Resveratrol first came to our attention in 1992, following reports of the cardioprotective effects of red wine. Thereafter, resveratrol was shown to exert antioxidant, anti‐inflammatory, anti‐proliferative,...